To the company that has invented the better mousetrap:
What do you do after you have patented your concept? Build it or license it?
If you think licensing is something anyone can do, think again! The specifics involved in the licensing of patents and trademarks determine the real value of the underlying creation to both parties involved. Certain errors may make your invention next to worthless.
Heartland Angels will be offering a discussion of "Licensing: The Paths to Take and the Pitfalls to Avoid." The meeting will be chaired by Heartland's President, Ronald L. Kirschner, M.D. The speakers will include:
Alan Thomas, MBA Director of the Office of Technology and Intellectual Property;
Pamela Cox, J.D., Marshall, Gerstein, and Borum;
Michael R. Bredahl, MBA, President of the Chicago Chapter of the Licensing Executive Society;
Valorie Calloway, J.D., Senior Counsel Global Patents of Kraft Foods; and
Jean Rumsfield, Pharm.D., Director of New Product Planning and Licensing of Fujisawa Healthcare.
A question and answer period will follow with an example of how a licensing negotiation might occur. The Panel will be moderated and hosted by Andrew Goldstein, J.D. of Freeborn & Peters LLP.
The event will take place at Freeborn & Peters' offices at 311 S. Wacker Dr., Suite 3000 on Monday, January 31, 2005 from 5:30 - 8:00 p.m.